To paraphrase a line from a classic country song, may we never take a single breath for granted. At the heart of the current COVID-19 outbreak is the struggle for precious air. Health-care professionals are doing all they can to make sure those entering their hospitals emerge with their health and breath restored.
One company, however, striving to go the “ounce of prevention” route is Ronkonkoma, New York-based G6 Materials Corp. (OTC:GPHBF). The outbreak of the COVID-19 has drastically altered the economic landscape, and G6 management is optimizing the business model to accommodate the new reality, addressing these new business opportunities.
According to CEO Daniel Stolyarov, explains, “There is an imminent demand for solutions that allow for the removal of viruses from the air and surfaces increasing the safety of the immediate environment. The Company has prioritized work in this sector and plans to address these market needs immediately.”
The G6 R&D department has developed a solution for air purification products that are designed to mitigate the threat of virus infection in confined spaces such as offices and industrial warehouses.
“There is substantial scientific evidence,” read Wednesday’s news release, “of antiviral and antibacterial effectiveness of graphene coatings. The Company has found a unique method to incorporate graphene in the air filtration systems making them more efficient in killing germs.”
G6 shares grabbed 1.25 cents, or 24.3%, to 6.4 cents, on 172,000 shares.
Health-care stocks were punished, much like other sectors in New York, losing 4.2% of their strength Wednesday.